Landmark study opens door to new cancer, aging treatments

(The Wistar Institute) Researchers at the Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers.

The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.

The study will be published online in Nature on Aug. 31.


 

Reply

The content of this field is kept private and will not be shown publicly.